Wall Street Breakfast cover image

Viking weight loss pill sees positive early data

Wall Street Breakfast

00:00

Promising Results from Viking's Obesity Pill Trials

This chapter discusses the promising results of Viking Therapeutics' VK2735, an experimental obesity medication. Patients on higher doses experienced significant weight loss, potentially paving the way for a future oral alternative to existing injection therapies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app